Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 104

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 104
---
 |   |     | $     | 142 |   |
| Adjusted EBITDA Margin(2)      |     |       |   3 | % |     |       |  28 | % |     |       |  33 | % |

| (1) | For purposes of the July Diligence Projections, Adjusted EBITDA (unburdened by SBC) is calculated by adding                                                    
 (a) interest income and expense, net; provision for income taxes; depreciation and amortization; and stock-based compensation expense, net; to (b) net income. |

| (2) | For purposes of the July Diligence Projections, Adjusted EBITDA Margin is calculated as Adjusted EBITDA 
 (unburdened by SBC) divided by net sales.                                                               |

STAAR does not intend to update or otherwise revise the above financial projections to reflect circumstances existing after the date when they were prepared or to reflect the occurrence of future events, even in the event that any or all of the assumptions underlying such unaudited prospective financial information are no longer appropriate. Interests of STAAR’s Executive Officers and Directors in the Merger In considering the recommendation of the Board that STAAR stockholders vote for the Merger Proposal and the Compensation Proposal, STAAR stockholders should be aware that the executive officers and directors of STAAR have certain interests in the transactions contemplated by the Merger Agreement that are or may be different from, or in addition to, the interests of STAAR stockholders generally. The Board was aware of these interests and considered them, among other matters, in determining that the Merger Agreement and the transactions contemplated thereby, including the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, are advisable, fair to and in the best interests of STAAR and its stockholders, approving, adopting and declaring advisable the execution and delivery of, and entry into, the Merger Agreement, and directing that the Merger Agreement be submitted to the STAAR stockholders for adoption at the Special Meeting. These interests are described in more detail below, and certain of them are quantified in the narrative below, including compensation that may become payable in connection with the Merger to STAAR’s named executive officers (which is the subject of an advisory (nonbinding) vote of STAAR stockholders). For more information, please see the section of this proxy statement titled “Proposal 2: The Compensation Proposal.” The dates